Annals of Oncology 29: 523, 2018 doi:10.1093/annonc/mdx058 Published online 24 March 2017 CORRIGENDUM ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4 lymphocyte count in lymphopenic metastatic breast cancer patients O. Tre´dan, C. Me´ne´trier-Caux, I. Ray-Coquard, G. Garin, C. Cropet, E. Verrone`se, T. Bachelot, P. Rebattu, P. E. Heudel, P. Cassier, S. Chabaud, T. Croughs, P. Dupont, A. C. Cadore, G. Clapisson, A. Delgado, C. Bardin-dit-Courageot, C. Rigal, A. N’Kodia, L. Gilles-Afchain, M. Morre, D. Pe´rol, J. Y. Blay & C. Caux Ann Oncol 2015; 26: 1353–1362 (doi:10.1093/annonc/mdv173) There is an error in the NCT number recorded for the Elypse-7 trial. The correct NCT reference is NCT01368107. V C The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: email@example.com. Downloaded from https://academic.oup.com/annonc/article-abstract/29/2/523/3084752 by Ed 'DeepDyve' Gillespie user on 16 March 2018
Annals of Oncology – Oxford University Press
Published: Feb 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera